Glenn Kline, DO
Surgery · Wyomissing, PANPI 1477596948
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $53,375 of the $55,165 with a category attached, or 96.8%. Medtronic accounts for 98.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $15,805 and has fallen 98.4% since, to $258 in 2025. Among surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $424.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$54K
- Cashflow Solutions, LLC$208
- GSK$152
- Organogenesis Inc.$100
- Tactile Systems Technology Inc$73
- Convatec Inc.$70
- plus $233 from 6 others
What the payments were for
- Consulting fees$2120%
- Speaking & faculty fees$53,37597%
- Food & beverage$1,5553%
- Education$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 95 | $54,330 |
| Cashflow Solutions, LLC | 6 | $208 |
| GSK | 8 | $152 |
| Organogenesis Inc. | 5 | $100 |
| Tactile Systems Technology Inc | 4 | $73 |
| Convatec Inc. | 3 | $70 |
| Bard Peripheral Vascular, Inc. | 2 | $67 |
| Venclose Inc. | 1 | $50 |
| Angiodynamics, Inc. | 2 | $47 |
| Boston Scientific | 2 | $39 |
| Biocompatibles, Inc. | 1 | $16 |
| Progenacare Global, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaSeal$38,950
- ClosureFast$14,425
- Surgidac$212
- Lympha Press Optimal Plus(US) BT$136
- PCD-51 731A (US) - White$136
- PCD-52 737A (US) White$136
How this compares
$55,165 in reported general payments places this provider in the 95th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $7,208 |
| Mupirocin | 15 | $71 |
| Cephalexin | 24 | $53 |
| Hydrochlorothiazide | 12 | $44 |
| Meloxicam | 19 | $30 |
Paid to pharmacies, not to this prescriber.
Other surgery in Wyomissing
- Andy KiserPittsburgh$1M
- Glenn SteeleDanville$698K
- Maher El ChaarAllentown$667K
- George EidPittsburgh$619K
- Paul CesanekAllentown$469K
- Clark GerhartPlains$317K
- Irina YermilovPlymouth Meeting$315K
- Eric PauliHershey$202K
- Ariel AballayPittsburgh$198K
- Ann RogersHershey$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.